Literature DB >> 15322932

Recognition of fungal pathogens by Toll-like receptors.

M G Netea1, C Van der Graaf, J W M Van der Meer, B J Kullberg.   

Abstract

Toll-like receptors (TLRs) have been identified as a major class of pattern-recognition receptors. Recognition of pathogen-associated molecular patterns by TLRs, either alone or in heterodimerization with other TLR or non-TLR receptors, induces signals responsible for the activation of the innate immune response. Recent studies have demonstrated a crucial involvement of TLRs in the recognition of fungal pathogens such as Candida albicans, Aspergillus fumigatus, and Cryptococcus neoformans. Through the study of fungal infection in knock-out mice deficient in either TLRs or TLR-associated adaptor molecules, it became apparent that specific TLRs such as TLR2 and TLR4 play differential roles in the activation of the various arms of the innate immune response. Recent data also suggest that TLRs offer escape mechanisms to certain pathogenic microorganisms, especially through TLR2-driven induction of anti-inflammatory cytokines. These new data have substantially increased our knowledge of the recognition of fungal pathogens, and the study of TLRs remains one of the most active areas of research in the field of fungal infections. Copyright 2004 Springer-Verlag

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15322932     DOI: 10.1007/s10096-004-1192-7

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  30 in total

1.  Involvement of CD14 and toll-like receptors in activation of human monocytes by Aspergillus fumigatus hyphae.

Authors:  J E Wang; A Warris; E A Ellingsen; P F Jørgensen; T H Flo; T Espevik; R Solberg; P E Verweij; A O Aasen
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

Review 2.  Molecular organization of the cell wall of Candida albicans.

Authors:  F M Klis; P de Groot; K Hellingwerf
Journal:  Med Mycol       Date:  2001       Impact factor: 4.076

Review 3.  Recognition of pathogen-associated molecular patterns by TLR family.

Authors:  Shizuo Akira; Hiroaki Hemmi
Journal:  Immunol Lett       Date:  2003-01-22       Impact factor: 3.685

4.  Toll-like receptor (TLR) signaling in response to Aspergillus fumigatus.

Authors:  Salamatu S Mambula; Keya Sau; Philipp Henneke; Douglas T Golenbock; Stuart M Levitz
Journal:  J Biol Chem       Date:  2002-08-08       Impact factor: 5.157

5.  Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System.

Authors:  C Beck-Sagué; W R Jarvis
Journal:  J Infect Dis       Date:  1993-05       Impact factor: 5.226

6.  Differential role of MyD88 in macrophage-mediated responses to opportunistic fungal pathogens.

Authors:  Kieren A Marr; S Arunmozhi Balajee; Thomas R Hawn; Adrian Ozinsky; Uyenvy Pham; Shizuo Akira; Alan Aderem; W Conrad Liles
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

Review 7.  Immunity to fungal infections.

Authors:  Luigina Romani
Journal:  Nat Rev Immunol       Date:  2004-01       Impact factor: 53.106

8.  Immune-deficient Drosophila melanogaster: a model for the innate immune response to human fungal pathogens.

Authors:  Anne-Marie Alarco; Anne Marcil; Jian Chen; Beat Suter; David Thomas; Malcolm Whiteway
Journal:  J Immunol       Date:  2004-05-01       Impact factor: 5.422

9.  Candida albicans phospholipomannan is sensed through toll-like receptors.

Authors:  Thierry Jouault; Stella Ibata-Ombetta; Osamu Takeuchi; Pierre-André Trinel; Paola Sacchetti; Philippe Lefebvre; Shizuo Akira; Daniel Poulain
Journal:  J Infect Dis       Date:  2003-06-23       Impact factor: 5.226

Review 10.  Toll-like receptors.

Authors:  Kiyoshi Takeda; Tsuneyasu Kaisho; Shizuo Akira
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

View more
  40 in total

1.  Immune response against Sporothrix schenckii in TLR-4-deficient mice.

Authors:  Micheli Fernanda Sassá; Lucas Souza Ferreira; Livia Carolina de Abreu Ribeiro; Iracilda Zeppone Carlos
Journal:  Mycopathologia       Date:  2012-07       Impact factor: 2.574

Review 2.  Innate immune responses to environmental allergens.

Authors:  Henk F Kauffman
Journal:  Clin Rev Allergy Immunol       Date:  2006-04       Impact factor: 8.667

Review 3.  Toll-like receptors and innate immunity.

Authors:  Satoshi Uematsu; Shizuo Akira
Journal:  J Mol Med (Berl)       Date:  2006-09       Impact factor: 4.599

Review 4.  Pathogen recognition and inflammatory signaling in innate immune defenses.

Authors:  Trine H Mogensen
Journal:  Clin Microbiol Rev       Date:  2009-04       Impact factor: 26.132

5.  TNF-alpha and TLR agonists increase susceptibility to HIV-1 transmission by human Langerhans cells ex vivo.

Authors:  Marein A W P de Jong; Lot de Witte; Menno J Oudhoff; Sonja I Gringhuis; Philippe Gallay; Teunis B H Geijtenbeek
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

6.  Altered expression of genes associated with innate immunity and inflammation in recalcitrant rhinosinusitis with polyps.

Authors:  Andrew P Lane; Quynh Ai Truong-Tran; Robert P Schleimer
Journal:  Am J Rhinol       Date:  2006 Mar-Apr

Review 7.  Cytokines and the regulation of fungus-specific CD4 T cell differentiation.

Authors:  Vanessa Espinosa; Amariliz Rivera
Journal:  Cytokine       Date:  2011-11-30       Impact factor: 3.861

Review 8.  Flying under the radar: Histoplasma capsulatum avoidance of innate immune recognition.

Authors:  Stephanie C Ray; Chad A Rappleye
Journal:  Semin Cell Dev Biol       Date:  2018-03-21       Impact factor: 7.727

Review 9.  Pattern recognition via the toll-like receptor system in the human female genital tract.

Authors:  Kaei Nasu; Hisashi Narahara
Journal:  Mediators Inflamm       Date:  2010-04-11       Impact factor: 4.711

10.  A murine model of contact lens-associated fusarium keratitis.

Authors:  Yan Sun; Jyotsna Chandra; Pranab Mukherjee; Loretta Szczotka-Flynn; Mahmoud A Ghannoum; Eric Pearlman
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-10-29       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.